34 related articles for article (PubMed ID: 22873754)
21. Transungual drug delivery: current status.
Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
[TBL] [Abstract][Full Text] [Related]
22. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
Brown M; Turner R; Wevrett SR
Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
[TBL] [Abstract][Full Text] [Related]
23. Iontophoretic drug delivery across the nail.
Delgado-Charro MB
Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
[TBL] [Abstract][Full Text] [Related]
24. Management of nail psoriasis by topical drug delivery: a pharmaceutical perspective.
Thatai P; Khan AB
Int J Dermatol; 2020 Aug; 59(8):915-925. PubMed ID: 32239692
[TBL] [Abstract][Full Text] [Related]
25. Formulations Based on Natural Ingredients for the Treatment of Nail Diseases.
Tampucci S; Terreni E; Zucchetti E; Burgalassi S; Chetoni P; Monti D
Curr Pharm Des; 2020; 26(5):556-565. PubMed ID: 31969086
[TBL] [Abstract][Full Text] [Related]
26. The human nail--barrier characterisation and permeation enhancement.
Walters KA; Abdalghafor HM; Lane ME
Int J Pharm; 2012 Oct; 435(1):10-21. PubMed ID: 22521879
[TBL] [Abstract][Full Text] [Related]
27. Analytical methods for determination of terbinafine hydrochloride in pharmaceuticals and biological materials.
Kanakapura B; Penmatsa VK
J Pharm Anal; 2016 Jun; 6(3):137-149. PubMed ID: 29403974
[TBL] [Abstract][Full Text] [Related]
28. Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro.
Hui X; Lindahl Å; Lamel S; Maibach HI
Drug Dev Ind Pharm; 2013 Sep; 39(9):1401-7. PubMed ID: 22873754
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.
Sigurgeirsson B; Ghannoum M
Expert Opin Investig Drugs; 2012 Oct; 21(10):1549-62. PubMed ID: 22876754
[TBL] [Abstract][Full Text] [Related]
30. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
31. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
32. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
33. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
